E
Reviva Pharmaceuticals Holdings, Inc. RVPH
$0.378 $0.00862.33% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income -28.92M -29.92M -33.01M -35.99M -39.84M
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 1.86M 912.60K 671.10K 606.70K 3.53M
Change in Net Operating Assets -2.95M -4.54M -976.50K 130.20K 4.22M
Cash from Operations -30.01M -33.54M -33.32M -35.26M -32.10M
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued 561.90K 976.90K 415.00K 415.00K 415.00K
Total Debt Repaid -669.70K -518.80K -554.50K -430.00K -750.50K
Issuance of Common Stock 23.44M 23.19M 34.05M 30.30M 33.15M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 23.33M 23.65M 33.91M 30.28M 32.82M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -6.68M -9.89M 586.50K -4.97M 718.10K